Saudi Arabia Blood Glucose Monitoring Devices Market Size, Share & Trends Analysis Report By Product (Self-monitoring, Continuous Glucose Monitoring), By End-use (Hospitals, Homecare), And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Saudi Arabia Blood Glucose Monitoring Devices Market Growth & Trends
The Saudi Arabia blood glucose monitoring devices market size is anticipated to reach USD 148.19 million by 2030, growing at a CAGR of 8.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. Technological advancements, the growing prevalence of diabetes in the country, and an aging population are the primary factors contributing to the market growth. Technological advancements and the growing emphasis on R&D activities in blood glucose monitoring devices in the country are expected to contribute to the market growth. For instance, in January 2024, King Abdullah University of Science and Technology (KAUST) and Saudi health tech firm amplifAI health collaborated to develop an innovative diabetes detection system.
Advancements in blood glucose monitoring (BGM) technology have significantly enhanced the monitoring experience for individuals with diabetes in Saudi Arabia. Modern BGM devices now come equipped with features such as wireless connectivity, smartphone integration, and continuous glucose monitoring (CGM) capabilities, providing users with convenient, accurate, and accessible tools to track their glucose levels more effectively. This empowers individuals to make informed decisions about their health and manage their condition with greater confidence.
Moreover, expanding healthcare infrastructure, including the proliferation of hospitals, clinics, and pharmacies, has played a crucial role in improving access to BGM devices across the country. This increased availability in Saudi Arabia ensures that individuals with diabetes have easier access to the necessary tools for monitoring and managing their condition, promoting better overall health outcomes.
Companies within the market are actively enhancing their product offerings by upgrading existing products, fostering strategic collaborations, exploring potential acquisitions, and seeking necessary government approvals. These efforts aim to expand their customer base and gain a larger share of the market. For instance, in April 2022, Medtronic collaborated with GE Healthcare to address the distinct needs and demand for care at ambulatory surgery centers and office-based laboratories. Customers can access a wide range of products, financial solutions, and service excellence through this new alliance.
Saudi Arabia Blood Glucose Monitoring Devices Market Report Highlights
Saudi Arabia Blood Glucose Monitoring Devices Market Growth & Trends
The Saudi Arabia blood glucose monitoring devices market size is anticipated to reach USD 148.19 million by 2030, growing at a CAGR of 8.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. Technological advancements, the growing prevalence of diabetes in the country, and an aging population are the primary factors contributing to the market growth. Technological advancements and the growing emphasis on R&D activities in blood glucose monitoring devices in the country are expected to contribute to the market growth. For instance, in January 2024, King Abdullah University of Science and Technology (KAUST) and Saudi health tech firm amplifAI health collaborated to develop an innovative diabetes detection system.
Advancements in blood glucose monitoring (BGM) technology have significantly enhanced the monitoring experience for individuals with diabetes in Saudi Arabia. Modern BGM devices now come equipped with features such as wireless connectivity, smartphone integration, and continuous glucose monitoring (CGM) capabilities, providing users with convenient, accurate, and accessible tools to track their glucose levels more effectively. This empowers individuals to make informed decisions about their health and manage their condition with greater confidence.
Moreover, expanding healthcare infrastructure, including the proliferation of hospitals, clinics, and pharmacies, has played a crucial role in improving access to BGM devices across the country. This increased availability in Saudi Arabia ensures that individuals with diabetes have easier access to the necessary tools for monitoring and managing their condition, promoting better overall health outcomes.
Companies within the market are actively enhancing their product offerings by upgrading existing products, fostering strategic collaborations, exploring potential acquisitions, and seeking necessary government approvals. These efforts aim to expand their customer base and gain a larger share of the market. For instance, in April 2022, Medtronic collaborated with GE Healthcare to address the distinct needs and demand for care at ambulatory surgery centers and office-based laboratories. Customers can access a wide range of products, financial solutions, and service excellence through this new alliance.
Saudi Arabia Blood Glucose Monitoring Devices Market Report Highlights
- In 2023, self-monitoring devices segment dominated the product segment by capturing a share of 67.1%. The level of convenience and easy accessibility of these devices are considered to boost the segment growth
- The continuous glucose monitoring devices segment is anticipated to grow at the fastest CAGR during the forecast period
- Among end-use, hospitals held a majority share of the market of 41.8% in 2023 due to increasing geriatric population and hospital admissions
- Home care segment is expected to grow at the fastest CAGR over the forecast period due to technological advancements leading to the easy usage of blood glucose monitoring devices
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. End-use
1.2.3. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. End-use outlook
2.3. Competitive Insights
CHAPTER 3. SAUDI ARABIA BLOOD GLUCOSE MONITORING DEVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing prevalence of diabetes
3.2.1.2. Technological Advancements
3.2.1.3. Growing awareness regarding diabetes management
3.2.2. Market Restraint Analysis
3.2.2.1. Stringent regulatory policies and regulations
3.3. Saudi Arabia Blood Glucose Monitoring Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
CHAPTER 4. SAUDI ARABIA BLOOD GLUCOSE MONITORING DEVICES MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Product Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Saudi Arabia Blood Glucose Monitoring Devices Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 - 2030 for the following
4.5. Self-Monitoring Devices
4.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.2. Blood Glucose Meters
4.5.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.3. Testing Strips
4.5.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.4. Lancets
4.5.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.6. Continuous Glucose-Monitoring Devices
4.6.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.6.2. Sensors
4.6.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.6.3. Transmitters & Receivers
4.6.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.6.4. Insulin Pump
4.6.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 5. SAUDI ARABIA BLOOD GLUCOSE MONITORING DEVICES MARKET: END-USE ESTIMATES & TREND ANALYSIS
5.1. End-use Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Saudi Arabia Blood Glucose Monitoring Devices Market by End-use Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 - 2030 for the following
5.5. Hospitals
5.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
5.6. Diagnostic Centers
5.6.1. Market estimates and forecasts 2018 - 2030 (USD Million)
5.7. Homecare
5.7.1. Market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.3. Key Company Market Share Analysis, 2023
6.4. Company Position Analysis, 2023
6.5. Company Categorization (Emerging Players, Innovators, and Leaders)
6.6. Company Profiles
6.6.1. Medtronic plc
6.6.1.1. Company overview
6.6.1.2. Financial performance
6.6.1.3. Product benchmarking
6.6.1.4. Strategic initiatives
6.6.2. Abbott Laboratories
6.6.2.1. Company overview
6.6.2.2. Financial performance
6.6.2.3. Product benchmarking
6.6.2.4. Strategic initiatives
6.6.3. F.Hoffmann-La-Ltd.
6.6.3.1. Company overview
6.6.3.2. Financial performance
6.6.3.3. Product benchmarking
6.6.3.4. Strategic initiatives
6.6.4. Bayer AG
6.6.4.1. Company overview
6.6.4.2. Financial performance
6.6.4.3. Product benchmarking
6.6.4.4. Strategic initiatives
6.6.5. Lifescan, Inc.
6.6.5.1. Company overview
6.6.5.2. Financial performance
6.6.5.3. Product benchmarking
6.6.5.4. Strategic initiatives
6.6.6. Dexcom Inc.
6.6.6.1. Company overview
6.6.6.2. Financial performance
6.6.6.3. Product benchmarking
6.6.6.4. Strategic initiatives
6.6.7. Insulet Corporation
6.6.7.1. Company overview
6.6.7.2. Financial performance
6.6.7.3. Product benchmarking
6.6.7.4. Strategic initiatives
6.6.8. Sanofi
6.6.8.1. Company overview
6.6.8.2. Financial performance
6.6.8.3. Product benchmarking
6.6.8.4. Strategic initiatives
6.6.9. Novo Nordisk A/S
6.6.9.1. Company overview
6.6.9.2. Financial performance
6.6.9.3. Product benchmarking
6.6.9.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. End-use
1.2.3. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. End-use outlook
2.3. Competitive Insights
CHAPTER 3. SAUDI ARABIA BLOOD GLUCOSE MONITORING DEVICES MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Growing prevalence of diabetes
3.2.1.2. Technological Advancements
3.2.1.3. Growing awareness regarding diabetes management
3.2.2. Market Restraint Analysis
3.2.2.1. Stringent regulatory policies and regulations
3.3. Saudi Arabia Blood Glucose Monitoring Devices Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic landscape
3.3.2.3. Social landscape
3.3.2.4. Technological landscape
3.3.2.5. Environmental landscape
3.3.2.6. Legal landscape
CHAPTER 4. SAUDI ARABIA BLOOD GLUCOSE MONITORING DEVICES MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Product Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Saudi Arabia Blood Glucose Monitoring Devices Market by Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 - 2030 for the following
4.5. Self-Monitoring Devices
4.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.2. Blood Glucose Meters
4.5.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.3. Testing Strips
4.5.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.5.4. Lancets
4.5.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.6. Continuous Glucose-Monitoring Devices
4.6.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.6.2. Sensors
4.6.2.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.6.3. Transmitters & Receivers
4.6.3.1. Market estimates and forecasts 2018 - 2030 (USD Million)
4.6.4. Insulin Pump
4.6.4.1. Market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 5. SAUDI ARABIA BLOOD GLUCOSE MONITORING DEVICES MARKET: END-USE ESTIMATES & TREND ANALYSIS
5.1. End-use Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Saudi Arabia Blood Glucose Monitoring Devices Market by End-use Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 - 2030 for the following
5.5. Hospitals
5.5.1. Market estimates and forecasts 2018 - 2030 (USD Million)
5.6. Diagnostic Centers
5.6.1. Market estimates and forecasts 2018 - 2030 (USD Million)
5.7. Homecare
5.7.1. Market estimates and forecasts 2018 - 2030 (USD Million)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company/Competition Categorization
6.3. Key Company Market Share Analysis, 2023
6.4. Company Position Analysis, 2023
6.5. Company Categorization (Emerging Players, Innovators, and Leaders)
6.6. Company Profiles
6.6.1. Medtronic plc
6.6.1.1. Company overview
6.6.1.2. Financial performance
6.6.1.3. Product benchmarking
6.6.1.4. Strategic initiatives
6.6.2. Abbott Laboratories
6.6.2.1. Company overview
6.6.2.2. Financial performance
6.6.2.3. Product benchmarking
6.6.2.4. Strategic initiatives
6.6.3. F.Hoffmann-La-Ltd.
6.6.3.1. Company overview
6.6.3.2. Financial performance
6.6.3.3. Product benchmarking
6.6.3.4. Strategic initiatives
6.6.4. Bayer AG
6.6.4.1. Company overview
6.6.4.2. Financial performance
6.6.4.3. Product benchmarking
6.6.4.4. Strategic initiatives
6.6.5. Lifescan, Inc.
6.6.5.1. Company overview
6.6.5.2. Financial performance
6.6.5.3. Product benchmarking
6.6.5.4. Strategic initiatives
6.6.6. Dexcom Inc.
6.6.6.1. Company overview
6.6.6.2. Financial performance
6.6.6.3. Product benchmarking
6.6.6.4. Strategic initiatives
6.6.7. Insulet Corporation
6.6.7.1. Company overview
6.6.7.2. Financial performance
6.6.7.3. Product benchmarking
6.6.7.4. Strategic initiatives
6.6.8. Sanofi
6.6.8.1. Company overview
6.6.8.2. Financial performance
6.6.8.3. Product benchmarking
6.6.8.4. Strategic initiatives
6.6.9. Novo Nordisk A/S
6.6.9.1. Company overview
6.6.9.2. Financial performance
6.6.9.3. Product benchmarking
6.6.9.4. Strategic initiatives
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 Saudi Arabia blood glucose monitoring devices market, by product, 2018 - 2030 (USD Million)
Table 4 Saudi Arabia blood glucose monitoring devices market, by end-use, 2018 - 2030 (USD Million)
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 Saudi Arabia blood glucose monitoring devices market, by product, 2018 - 2030 (USD Million)
Table 4 Saudi Arabia blood glucose monitoring devices market, by end-use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Saudi Arabia blood glucose monitoring devices market: Market outlook
Fig. 9 Saudi Arabia blood glucose monitoring devices market competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Saudi Arabia blood glucose monitoring devices market driver impact
Fig. 15 Saudi Arabia blood glucose monitoring devices market restraint impact
Fig. 16 Saudi Arabia blood glucose monitoring devices market: product movement analysis
Fig. 17 Saudi Arabia blood glucose monitoring devices market: product outlook and key takeaways
Fig. 18 Self-monitoring devices market estimates and forecast, 2018 - 2030
Fig. 19 Blood glucose meters market estimates and forecast, 2018 - 2030
Fig. 20 Testing strips market estimates and forecast, 2018 - 2030
Fig. 21 Lancets market estimates and forecast, 2018 - 2030
Fig. 22 Continuous glucose monitoring devices market estimates and forecast, 2018 - 2030
Fig. 23 Sensors market estimates and forecast, 2018 - 2030
Fig. 24 Transmitters & receivers market estimates and forecast, 2018 - 2030
Fig. 25 Insulin pump market estimates and forecast, 2018 - 2030
Fig. 26 Saudi Arabia blood glucose monitoring devices market: end-use movement analysis
Fig. 27 Saudi Arabia blood glucose monitoring devices market: end-use outlook and key takeaways
Fig. 28 Hospitals market estimates and forecast, 2018 - 2030
Fig. 29 Diagnostic centers market estimates and forecast, 2018 - 2030
Fig. 30 Homecare market estimates and forecast, 2018 - 2030
Fig. 31 Participant categorization- Saudi Arabia blood glucose monitoring devices market
Fig. 32 Market share of key market players- Saudi Arabia blood glucose monitoring devices market
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Saudi Arabia blood glucose monitoring devices market: Market outlook
Fig. 9 Saudi Arabia blood glucose monitoring devices market competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Saudi Arabia blood glucose monitoring devices market driver impact
Fig. 15 Saudi Arabia blood glucose monitoring devices market restraint impact
Fig. 16 Saudi Arabia blood glucose monitoring devices market: product movement analysis
Fig. 17 Saudi Arabia blood glucose monitoring devices market: product outlook and key takeaways
Fig. 18 Self-monitoring devices market estimates and forecast, 2018 - 2030
Fig. 19 Blood glucose meters market estimates and forecast, 2018 - 2030
Fig. 20 Testing strips market estimates and forecast, 2018 - 2030
Fig. 21 Lancets market estimates and forecast, 2018 - 2030
Fig. 22 Continuous glucose monitoring devices market estimates and forecast, 2018 - 2030
Fig. 23 Sensors market estimates and forecast, 2018 - 2030
Fig. 24 Transmitters & receivers market estimates and forecast, 2018 - 2030
Fig. 25 Insulin pump market estimates and forecast, 2018 - 2030
Fig. 26 Saudi Arabia blood glucose monitoring devices market: end-use movement analysis
Fig. 27 Saudi Arabia blood glucose monitoring devices market: end-use outlook and key takeaways
Fig. 28 Hospitals market estimates and forecast, 2018 - 2030
Fig. 29 Diagnostic centers market estimates and forecast, 2018 - 2030
Fig. 30 Homecare market estimates and forecast, 2018 - 2030
Fig. 31 Participant categorization- Saudi Arabia blood glucose monitoring devices market
Fig. 32 Market share of key market players- Saudi Arabia blood glucose monitoring devices market
